SA
COLL icon

Sanctuary Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Sanctuary Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,101
Closed -$1.39M – 2548
2025
Q4 		$1.39M Sell
30,101
-4,910
-14% -$205K 0.01% 1137
2025
Q3 		$1.23M Sell
35,011
-6,824
-16% -$237K 0.01% 1168
2025
Q2 		$1.24M Buy
41,835
+21,150
+102% +$603K 0.01% 1093
2025
Q1 		$617K Buy
20,685
+1,757
+9% +$53.7K ﹤0.01% 1389
2024
Q4 		$615K Buy
18,928
+952
+5% +$31.5K ﹤0.01% 1569
2024
Q3 		$539K Buy
17,976
+1,731
+11% +$61.7K ﹤0.01% 1651
2024
Q2 		$592K Buy
+16,245
New +$563K ﹤0.01% 1529

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Sanctuary Advisors's COLL Position: Q1 2026 in Review

Sanctuary Advisors sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 30,101 shares — an estimated $1.39M sold.

Sanctuary Advisors first reported a position in COLL in Q2 2024 and held it in 7 quarters. The position peaked at $1.39M in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Sanctuary Advisors reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Sanctuary Advisors sold 30,101 Collegium Pharmaceutical shares in Q1 2026, an estimated $1.39M.
  • Sanctuary Advisors first reported a position in Collegium Pharmaceutical in Q2 2024 and held it in 7 quarters.
  • Sanctuary Advisors's Collegium Pharmaceutical position peaked at $1.39M in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.